Advanced search
Publication Cover
Annals of Medicine Volume 53, 2021 - Issue 1
Submit an article Journal homepage
1,581
Views
0
CrossRef citations to date
0
Altmetric
Dermatology

Stratification of atopic dermatitis patients by patterns of response to proactive therapy with topical tacrolimus: low serum IgE levels and inadequately controlled disease activity at the start of treatment predict its failure

Hiroko Kasaia Department of Dermatology, Keio University School of Medicine, Tokyo, Japan;b Department of Dermatology, Kitasato University Kitasato Institute Hospital, Tokyo, Japan
,
Hiroshi Kawasakia Department of Dermatology, Keio University School of Medicine, Tokyo, Japan;c Medical Sciences Innovation Hub Program, RIKEN, Kanagawa, Japan
,
Ayano Fukushima-Nomuraa Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
,
Fumiyo Yasuda-Sekiguchia Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
,
Masayuki Amagaia Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
,
Tamotsu Ebiharaa Department of Dermatology, Keio University School of Medicine, Tokyo, Japan;d Department of Dermatology, Tokyo Saiseikai Central Hospital, Tokyo, Japan
&
Keiji Tanesea Department of Dermatology, Keio University School of Medicine, Tokyo, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1409-6475
ORCID Icon show all
Pages 2207-2216 | Received 01 Jul 2021, Accepted 02 Nov 2021, Published online: 19 Nov 2021

References

  • Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis work group. J Am Acad Dermatol. 2014;70(2):338–351.
  • Langan S, Irvine A, Weidinger S. Atopic dermatitis. Lancet. 2020;396(10247):345–360.
  • Katoh N, Ohya Y, Ikeda M, et al. Clinical practice guidelines for the management of atopic dermatitis 2018. J Dermatol. 2019;46(12):1053–1101.
  • Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116–132.
  • Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based european guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32(5):657–682.
  • Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technology Assessment. 2000;4(37):1–191.
  • Nakahara T, Morimoto H, Murakami N, et al. Mechanistic insights into topical tacrolimus for the treatment of atopic dermatitis. Pediatr Allergy Immunol. 2018;29(3):233–238.
  • Czarnecka-Operacz M, Jenerowicz D. Topical calcineurin inhibitors in the treatment of atopic dermatitis – an update on safety issues. J Dtsch Dermatol Ges. 2012;10(3):167–172.
  • Wollenberg A, Reitamo S, Girolomoni G, et al. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy. 2008;63(7):742–750.
  • European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the scorad index. Dermatology. 1993;186(1):763–769.
  • Hanifin J, Rajka D. Diagnostic features of atopic dermatitis. Acta Dermato-Venereologica. 1980;92(Suppl):44–47.
  • R Core Team 2019. “R: A Language and Environment for Statistical Computing.” Vienna, Austria: R Foundation for Statistical Computing. Available from: https://www.r-project.org/
  • Wickham H. 2016. “ggplot2: Elegant Graphics for Data Analysis.” Springer-Verlag New York. Available from: https://ggplot2.tidyverse.org/
  • Hanifin JM, Ling MR, Langley R, et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy. Journal of the American Academy of Dermatology. 2001;44(1):S28–S38.
  • Paller AS, Tom WL, Lebwohl MG, et al. Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults. J Am Acad Dermatol. 2016;75(3):494–503.e6.
  • Tokura Y. Extrinsic and intrinsic types of atopic dermatitis. J Dermatol Sci. 2010;58(1):1–7.
  • Iannone M, Tonini G, Janowska A, et al. Definition of treatment goals in terms of clinician-reported disease severity and patient-reported outcomes in moderate-to-severe adult atopic dermatitis: a systematic review. Curr Med Res Opin. 2021;37(8):1295–1301.
  • Kataoka Y. Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis. J Dermatol. 2014;41(3):221–229.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.